)
CareMax (CMAX) investor relations material
CareMax Q2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Reported a net loss of $170.6 million for Q2 2024, compared to $32.4 million in Q2 2023, driven by $133.0 million in asset impairments and ongoing operational losses.
Revenue for Q2 2024 was $198.6 million, down 11.5%–12% year-over-year, with declines across Medicaid, government value-based care, and other revenue streams.
Adjusted EBITDA was $(11.2) million, down from $7.0 million in Q2 2023.
Platform Contribution for Q2 2024 was $3.7 million, down from $28.6 million in Q2 2023.
Medicare Advantage membership grew 1% year-over-year to 104,000, while total membership declined 13% to 236,500.
Financial highlights
Q2 2024 revenue: $198.6 million, down from $224.4 million in Q2 2023.
Operating loss for Q2 2024: $152.7 million, compared to $3.8 million in Q2 2023.
Net loss per share: $(44.79) for Q2 2024, compared to $(8.70) in Q2 2023.
Medical Expense Ratio for Q2 2024: 86.2%, up from 84.6% in Q2 2023.
Cash and cash equivalents at June 30, 2024: $16.4 million, down from $65.5 million at year-end 2023.
Outlook and guidance
Management is pursuing cost reductions, asset divestitures, refinancing, and evaluating strategic alternatives to address liquidity needs.
If unable to implement plans or secure relief, a Chapter 11 restructuring is likely.
Waivers on credit agreement defaults extended through August 15, 2024, but future compliance is uncertain.
Focus remains on clinical initiatives and managing medical expense ratio.
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)